SAN DIEGO, Calif., March 28, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB: AXIM), has entered into a Term Sheet Agreement with a U.S.-based controlled-substances API (Active Pharmaceutical Ingredient) production company to develop a dronabinol-based functional, controlled-release chewing gum product based on AXIM IP and technology.
Tag Archives: Marinol
Medical marijuana patient and doctor defend the usage of marijuana for those with illnesses and how it contributes to the betterment of their health.
On June 16, 2016, the Brookings Institute published “Worry about bad marijuana—not Big Marijuana,” a paper by John Hudak and Jonathan Rauch that argues against the mindset of “Big Marijuana” alarmists.
It is often thought that the economic future for recreational marijuana is relatively limited. The people who use it for fun will eventually move from the black market to the legal market.
The American Academy of Neurology has reported promising results in early trials of the drug, Epidiolex, which is 98 percent pure cannabidiol, in treating severe forms of pediatric epilepsy, including Dravet syndrome and Lennox-Gastaut syndrome.
Ancient remedies reveal medical marijuana is no newcomer. Its history extends far back into the mists of time.